Asymchem Laboratories (Tianjin) Co., Ltd. Stock

Stocks

002821

CNE100002BZ6

Pharmaceuticals

OTC Markets Traded
End-of-day quote 2026-08-18 5-day change 1st Jan Change
177.25 CNY +0.07% Intraday chart for Asymchem Laboratories (Tianjin) Co., Ltd. +0.71% +90.73%

Valuation: Asymchem Laboratories (Tianjin) Co., Ltd.

Market Cap 61.87B 9.17B 7.92B 7.46B 6.78B 12.75B 879B 12.93B 87.46B 34.27B 440B 34.45B 33.7B 1,464B P/E 2026 *
45.5x
P/E 2027 * 36.5x
Enterprise Value 56.82B 8.43B 7.28B 6.85B 6.22B 11.71B 807B 11.88B 80.32B 31.48B 404B 31.64B 30.95B 1,345B EV / Sales 2026 *
7.03x
EV / Sales 2027 * 5.91x
Free-Float
61.14%
Yield 2026 *
0.83%
Yield 2027 * 1.01%
07-31 Asymchem Laboratories to Subscribe for Subsidiary's New Shares for 1.05 Billion Yuan; Shares Up 6% MT
07-29 Shanghai Asymchem Biotechnology Development Co., Ltd. announced that it expects to receive CNY 1.239699995 billion in funding from Asymchem Laboratories Co., Ltd., Suzhou Gao Ling Qirui Healthcare Investment, L.P. and another investor CI
07-27 AsymBio, Subsidiary of Asymchem Group Kicks Off Construction of Fengxian R&D Building CI
07-10 Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to 175.98 Yuan From 132.37 Yuan, Keeps at Buy MT
07-10 Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to HK$131.48 From HK$115.43, Keeps at Buy MT
06-11 Asymchem Laboratories Co., Ltd. Approves Final Profit Distribution Plan to Be Implemented (A Shares) for 2025, Payable on June 26, 2026 CI
05-27 Asymbio Showcases Comprehensive Conjugation Toolbox to Support Process Development for Next-Generation Bioconjugates CI
05-20 Citigroup's long position in H shares of Asymchem Laboratories (Tianjin) decreases to 4.99% on May 14 from 5.66%, HKEX filing says RE
05-15 Asymchem Laboratories Co., Ltd. Recommends Final Dividend for the Year Ended 31 December 2025, Payable on 24 July 2026 CI
05-13 Citigroup's long position in H-shares of Asymchem Laboratories (Tianjin) decreases to 5.36% on May 7, HKEX says RE
05-04 JPMorgan Chase's long position in H-shares of Asymchem Laboratories (Tianjin) decreases to 7.64% on Apr 28 from 8.18%, HKEX filing shows RE
04-28 Asymchem Laboratories' Profit Falls 6.8% in Q1; Shares Rise 8% MT
04-27 Asymchem Laboratories Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
1 day+0.07%
1 week+0.71%
Current month+16.12%
1 month+9.42%
3 months+50.25%
6 months+76.23%
Current year+90.73%
1 week 167.3
Extreme 167.3
180.58
1 month 142.43
Extreme 142.43
188
Current year 91.33
Extreme 91.33
200
1 year 88.46
Extreme 88.46
200
3 years 59.55
Extreme 59.55
200
5 years 59.55
Extreme 59.55
380.35
10 years 13.09
Extreme 13.085713
380.35
Manager TitleAgeSince
Chief Executive Officer 70 1998-10-06
Chief Executive Officer 49 2022-01-18
President - -
Director TitleAgeSince
Director/Board Member 49 2011-07-17
Chairman 70 1998-10-06
Director/Board Member 65 2011-07-17
Date Insider Type Main position Quantity % Market Cap.
7/14/26
Tianjin Guorong Business Information Consulting Co. Ltd.
OtherCompany -315,000 1.1317%
7/8/26 Other

Chief Executive Officer

25,000 0.0898%
7/8/26
Tianjin Guorong Business Information Consulting Co. Ltd.
OtherCompany 25,000 0.0898%
Change 5-day change 1-year change 3-year change Capi.($)
+0.07%+0.71%+62.47%+40.47% 9.15B
+3.28%+0.48%+74.89%+123.42% 1,055B
+3.24%+4.18%+53.56%+56.91% 632B
+3.03%+2.97%+24.66%+71.52% 442B
+1.35%-2.17%+40.98%+41.50% 351B
+1.75%-0.24%+25.28%+40.46% 290B
+2.13%-0.32%+0.58%+10.77% 243B
+1.61%+2.92%+45.72%+62.86% 227B
+1.35%-3.53%-14.72%-52.63% 200B
+3.05%+5.47%+21.36%+88.71% 172B
Average +2.14%-1.17%+33.48%+48.40% 362.17B
Weighted average by Cap. +2.66%-1.86%+43.43%+67.94%

Financials

2026 *2027 *
Net sales 8.08B 1.2B 1.04B 974M 885M 1.66B 115B 1.69B 11.42B 4.48B 57.43B 4.5B 4.4B 191B 9.72B 1.44B 1.25B 1.17B 1.06B 2B 138B 2.03B 13.74B 5.39B 69.08B 5.41B 5.3B 230B
Net income 1.4B 208M 180M 169M 154M 289M 19.92B 293M 1.98B 777M 9.96B 781M 764M 33.19B 1.77B 262M 227M 213M 194M 364M 25.14B 370M 2.5B 980M 12.57B 985M 964M 41.88B
Net Debt -5.05B -749M -647M -608M -553M -1.04B -71.74B -1.06B -7.14B -2.8B -35.88B -2.81B -2.75B -120B -4.39B -651M -563M -529M -481M -905M -62.41B -918M -6.21B -2.43B -31.21B -2.45B -2.39B -104B
Logo Asymchem Laboratories (Tianjin) Co., Ltd.
Asymchem Laboratories Tianjin Co Ltd is a China-based company mainly engaged in providing one-stop comprehensive services for pharmaceutical outsourcing. The Company's business includes customized research and development and production of small molecule drugs (CDMO), chemical macromolecule CDMO, clinical research services, formulation CDMO, biological macromolecule CDMO, technology output and synthetic biology. The Company's product categories cover peptides, oligonucleotides, monoclonal antibodies, antibody-conjugated drugs and messenger RNA. The Company mainly conducts its business in domestic and foreign markets.
Employees
10,617
Date Price Change Volume
26-08-17 CN¥177.25 +0.07% 10,432,920
26-08-17 CN¥177.12 +3.46% 12,059,671
26-08-14 CN¥171.20 -1.50% 11,747,748
26-08-13 CN¥173.81 -0.68% 17,410,824
26-08-12 CN¥175.00 -0.36% 11,108,829
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
177.25CNY
Average target price
160.45CNY
Spread / Average Target
-9.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002821 Stock